Standard Podcast [31:15m]: Play Now | Play in Popup | Download

Heart of Health - do you have one?

Helen Keller: “The heresy of one age becomes the orthodoxy of the next.”

Is it time to quit viewing EDTA chelation therapy for heart disease as medical heresy, and start using on a more wide spread basis in this new age of medicine?

This is Part 2 of Effective Alternatives for Treating Cardiovascular Disease – EDTA Chelation as Front-Runner.

Trial to Assess Chelation Therapy, TACT trial: We discuss this placebo-controlled trial sponsored by the National Institute of Health. This research is worthwhile, but in our opinion we already have enough empirical and research-based evidence to be offering intravenous EDTA chelation therapy to cardiovascular disease patients now. Regardless, and unfortunately, it appears that the so-called ‘quack busters’ - the phony ‘experts’ from the ‘National Council Against Health Fraud’ - are trying to sabotage the TACT trial in attempt to expunge this safe, simple, effective and inexpensive alternative treatment for cardiovascular diseases. Next week we shine the TGM spotlight on the ‘quack busters.’

EDTA Monograph by Cardiologist Dr. Stephen Olmstead: “The preponderance of clinical reports in the medical literature support a claim of efficacy for symptomatic angina, intermittent claudication and critical leg ischemia.” Note: we are currently trying to get in touch with Dr. Olmstead to find a digital version of the Monograph and link to it from the TGM website.

EDTA Chelation Therapy as ‘Holistic’ Therapy: EDTA is not a ‘natural’ product. It is an artificial, synthetic drug. However, one could argue that it is a ‘holistic’ therapy since it is infused systemically, and reaches and potentially detoxifies heavy metals from most of our tissues and organs.

EDTA Package Insert Altered by Abbott Labs to Remove Cardiovascular Disease as an Indication for the Drug: Even by the 1960s existing evidence for EDTAs efficacy to treat cardiovascular disease was enough for Abbott Labs to include it as one of the ‘indications’ for the drug. Later the language was arbitrarily changed, stating that EDTA is ‘not’ indicated for this purpose. To the best of our knowledge, this mysterious manipulation of medical product information is unprecedented in medical history.

Off-Label Drug Legislation the Result of One Doctor’s Fight Against the FDA to Be Able to Offer EDTA Chelation to His Patients. In 1981, during a ‘David and Goliath’ type battle, Dr. Ray Evers from Alabama fought the US Food and Drug Administration for his right to use EDTA to treat his patients with cardiovascular disease. With EDTA in his ’sling’ he toppled the FDA. The federal court ruling in favor of Dr. Evers stated that the FDA’s arguments against Dr. Evers were “nonsensical.” This was a huge victory for patients and the advancement of good medicine not only because it lessened the FDA’s tyranny against our medical freedoms, but also because it resulted in today’s doctors’ ability to prescribe drugs ‘off-label.’ This means we  can now legally use any medication for any purpose, even though that purpose – that ‘indication’ – is not necessarily approved by the FDA. All this because of Dr. Ever’s fight for EDTA! Kevin asks the logical question: Why was the FDA trying to regulate an Alabama doctor’s medical practice? And Dr. Douglass asks: What political influences – what constituencies/vested interests – may have teamed up with the FDA to start that battle against EDTA and Dr. Evers in the first place? We’ll may never know.

Dr. Rogers vs. the Florida State Board of Medical Examiners: Dr. Robert Rogers, MD fought the Florida Medical Board all the way to the Florida Supreme Court over his right to provide EDTA to his patients with cardiovascular disease, and won. The Florida Supreme Court ruled that the action of the Florida medical board restraining Dr. Rogers from utilization of chelation therapy for his patients was “an arbitrary and unreasonable exercise of the state’s police power.”

Note: To download full report as a pdf file click on the document.

Negative Published Studies On EDTA Chelation Therapy For Treating Cardiovascular Disease: There have been six negative studies. We discuss them, and how they all either have major irregularities from a scientific standpoint, or have negative conclusions even though the results reported in the studies were positive. For an excellent online resource with commentary and analysis of each one of the studies, go to http://www.drcranton.com/chelation.htm And as we’ve mentioned on previous shows, a good resource for finding physicians who are likely to be offering intravenous EDTA is the organization American College for Advancement in Medicine at acam.org.

Good Medicine Word Of The Week: Off-label use - in commemoration of Dr. Ray Evers and his ‘David and Goliath’ fight against the FDA. Now American physicians can use EDTA, and any other drugs, for purposes other than what the FDA approves them for.

Next week: If intravenous EDTA chelation really is a safe, effective and inexpensive alternative to bypass surgery and angioplasty, do you think there might be attempts by conventional medicine to squelch it? We’ll shine the TGM spotlight on the phoney ‘quack busters‘ and the so-called National Councel Against Health Fraud (or is it the ‘National Councel of Health Frauds’?) in their obvious efforts to supress the TACT trial and our access to EDTA chelation therapy for treating heart disease.